To the Editor: Dr Sheets and colleagues1 used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database to retrospectively compare surrogate outcomes (claims) for patients with non–metastatic prostate cancer treated with 3 radiation modalities—conformal radiation therapy, IMRT, and proton therapy—advances expected to improve disease control and toxicity outcomes through improved radiation dose distribution.
Mendenhall NP, Schild S, Slater J. Radiation Therapy Modalities for Prostate Cancer. JAMA. 2012;308(5):450. doi:10.1001/jama.2012.8112
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: